Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Related
Posts
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Part 2: How is hepatitis C treated?
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
